| Quality by design I: application of failure mode effect analysis (FMEA) and Plackett–Burman design of experiments in the identification of “main factors” in the formulation and … R Fahmy, R Kona, R Dandu, W Xie, G Claycamp, SW Hoag AAPS pharmscitech 13, 1243-1254, 2012 | 141 | 2012 |
| Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy SH Tabasi, V Moolchandani, R Fahmy, SW Hoag International journal of pharmaceutics 382 (1-2), 1-6, 2009 | 83 | 2009 |
| Application of in-line near infrared spectroscopy and multivariate batch modeling for process monitoring in fluid bed granulation R Kona, H Qu, R Mattes, B Jancsik, RM Fahmy, SW Hoag International journal of pharmaceutics 452 (1-2), 63-72, 2013 | 78 | 2013 |
| Quality by design, part I: application of NIR spectroscopy to monitor tablet manufacturing process SH Tabasi, R Fahmy, D Bensley, C O'Brien, SW Hoag Journal of pharmaceutical sciences 97 (9), 4040-4051, 2008 | 78 | 2008 |
| Quality by design, part II: application of NIR spectroscopy to monitor the coating process for a pharmaceutical sustained release product SH Tabasi, R Fahmy, D Bensley, C O'Brien, SW Hoag Journal of pharmaceutical sciences 97 (9), 4052-4066, 2008 | 75 | 2008 |
| Assessment of the critical factors affecting the porosity of roller compacted ribbons and the feasibility of using NIR chemical imaging to evaluate the porosity distribution H Lim, VS Dave, L Kidder, EN Lewis, R Fahmy, SW Hoag International journal of pharmaceutics 410 (1-2), 1-8, 2011 | 72 | 2011 |
| Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms AS Tatavarti, R Fahmy, H Wu, AS Hussain, W Marnane, D Bensley, ... aaps Pharmscitech 6, E91-E99, 2005 | 55 | 2005 |
| Quality by design, part III: study of curing process of sustained release coated products using NIR spectroscopy SH Tabasi, R Fahmy, D Bensley, C O'Brien, SW Hoag Journal of pharmaceutical sciences 97 (9), 4067-4086, 2008 | 39 | 2008 |
| Eudragit® RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules … VS Dave, RM Fahmy, D Bensley, SW Hoag Drug Development and Industrial Pharmacy 38 (10), 1240-1253, 2012 | 28 | 2012 |
| Investigation of the physical–mechanical properties of Eudragit® RS PO/RL PO and their mixtures with common pharmaceutical excipients VS Dave, RM Fahmy, SW Hoag Drug development and industrial pharmacy 39 (7), 1113-1125, 2013 | 25 | 2013 |
| Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments Y Dong, H Qu, N Pavurala, J Wang, V Sekar, MN Martinez, R Fahmy, ... International journal of pharmaceutics 544 (1), 254-264, 2018 | 22 | 2018 |
| Quality-by-design II: application of quantitative risk analysis to the formulation of ciprofloxacin tablets HG Claycamp, R Kona, R Fahmy, SW Hoag AAPS PharmSciTech 17, 233-244, 2016 | 21 | 2016 |
| Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering … VS Dave, RM Fahmy, SW Hoag Drug Development and Industrial Pharmacy 41 (6), 898-905, 2015 | 18 | 2015 |
| Quality-by-design III: application of near-infrared spectroscopy to monitor roller compaction in-process and product quality attributes of immediate release tablets R Kona, RM Fahmy, G Claycamp, JE Polli, M Martinez, SW Hoag AAPS PharmSciTech 16, 202-216, 2015 | 17 | 2015 |
| Prediction of dissolution of sustained release coated ciprofloxacin beads using near-infrared spectroscopy and process parameters: a data fusion approach A Ibrahim, BH Kothari, R Fahmy, SW Hoag AAPS PharmSciTech 20, 1-9, 2019 | 15 | 2019 |
| Use of modeling and simulation tools for understanding the impact of formulation on the absorption of a low solubility compound: ciprofloxacin M Martinez, B Mistry, V Lukacova, J Polli, S Hoag, T Dowling, R Kona, ... The AAPS journal 18, 886-897, 2016 | 11 | 2016 |
| A systematic approach of employing quality by design principles: Risk assessment and design of experiments to demonstrate process understanding and identify the critical … BH Kothari, R Fahmy, HG Claycamp, CMV Moore, S Chatterjee, SW Hoag AAPS PharmSciTech 18, 1135-1157, 2017 | 10 | 2017 |
| The scientific basis for establishing solubility criteria for veterinary species MN Martinez, R Fahmy Journal of veterinary pharmacology and therapeutics 35, 81-86, 2012 | 10 | 2012 |
| Formulation and design of veterinary tablets R Fahmy, D Danielson, M Martinez Pharmaceutical Dosage Forms-Tablets, 399-448, 2008 | 10 | 2008 |
| Testing the in-vitro product performance of nanomaterial-based drug products: view of the USP expert panel MG Wacker, X Lu, M Burke, I Nir, R Fahmy DISSOLUTION TECHNOLOGIES 29 (1), 6-20, 2022 | 9 | 2022 |
Stephen W. Hoag, Ph.D.Professor of Pharmaceutical Sciences在 rx.umaryland.edu 的电子邮件经过验证
